Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05471102
Other study ID # MS-38-2022
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 3, 2022
Est. completion date November 30, 2022

Study information

Verified date July 2022
Source Cairo University
Contact amr essam
Phone 01004365349
Email amro_394@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The patients will be divided into 2 groups: Group (A) - Study group: Cases managed by lower segment resection with ligation of the anterior division of the internal iliac artery Group (B) - Control group: Cases managed by lower segment resection without ligation of the anterior division of the internal iliac artery The following operative details will be recorded: - Estimation of total blood loss - Pre and 24-h post-operative hemoglobin (g/dl). - The need for blood transfusion and its amount intra or postoperative will be recorded - Operative time and postoperative hospital stay will be recorded. - Close post-operative monitoring of the patients' vital signs, drain output, and urine output - Presence or absence of intraoperative complications; bladder, ureteric, bowel, or vascular injuries will be recorded. - Monitoring for postoperative morbidities


Description:

The patients will be divided into 2 groups: Group (A) - Study group: Cases managed by uterine lower segment resection with ligation of the anterior division of the internal iliac artery (4 cm distal to the bifurcation of the common iliac artery). Group (B) - Control group: Cases managed by uterine lower segment resection without ligation of the anterior division of the internal iliac artery. In both groups, bilateral uterine artery ligation at 2 levels will be done; bilateral ligation at a level below the lower most placental part, followed by bilateral uterine artery ligation at the level of the hysterotomy incision. The following operative details will be recorded: - Estimation of total blood loss - Pre and 24-h post-operative hemoglobin (g/dl). - The need for blood transfusion and its amount intra or post-operative will be recorded - Operative time and postoperative hospital stay will be recorded. - Close post-operative monitoring of the patients' vital signs, drain output, and urine output - Presence or absence of intraoperative complications; bladder, ureteric, bowel, or vascular injuries will be recorded. - Monitoring for postoperative morbidities


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date November 30, 2022
Est. primary completion date November 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - Age: 20-40 years old. - Pregnancy of singleton living fetus. - Previous one or more cesarean sections. - Gestational age: > 36 weeks. - Elective termination of pregnancy. - Cases not requiring preoperative blood transfusion. - Cases with focal area of placental adherence or invasion leaving sufficient healthy myometrial tissue for uterine repair and preservation. - The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesical hypervascularity". Exclusion Criteria: - Multifetal pregnancy. - More than four previous sections. - Emergency termination of pregnancy due to antepartum hemorrhage, placental separation or rupture uterus. - Intrauterine fetal death. - Women with history of any medical disorder with pregnancy eg. Gestational diabetes and hypertension. - Premature rupture of membranes. - Cases misdiagnosed as placenta accreta by ultrasound preoperatively, and spontaneous full placental separation occurred intraoperative. "will be excluded before randomization" - Cases with PAS with total invasion involving all placental lobules. - Cases who will be managed by cesarean hysterectomy due to uncontrolled intraoperative bleeding.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Study group: lower segment resection with ligation of the anterior division of the internal iliac artery
Cases managed by uterine lower segment resection with ligation ((suturing)) of the anterior division of the internal iliac artery (4 cm distal to the bifurcation of the common iliac artery); in addition to the bilateral uterine artery ligation at 2 levels; bilateral ligation at a level below the lower most placental part followed by bilateral uterine artery ligation at the level of the hysterotomy incision.
Control group: lower segment resection without ligation of the anterior division of the internal iliac artery
Cases managed by uterine lower segment resection without ligation of the anterior division of the internal iliac artery. (i.e., only bilateral ligation at a level below the lower most placental part followed by bilateral uterine artery ligation at the level of the hysterotomy incision).

Locations

Country Name City State
Egypt Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of blood loss intra-operative Amount of blood loss intra-operative during operation
Primary Amount of blood loss 24 hours post-operative Amount of blood loss 24 hours post-operative 24 hours post-operative
Secondary Operative time duration of the surgery during operation
Secondary Number of blood units transfused Number of blood units transfused within 24 hours after surgery within 24 hours after surgery
See also
  Status Clinical Trial Phase
Completed NCT04579172 - Conservative Management of Morbidly Adherent Anterior Situated Placenta N/A
Completed NCT04593303 - Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum N/A
Recruiting NCT03638024 - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Not yet recruiting NCT06100640 - Paracervical Pouch in Placenta Accreta Spectrum
Completed NCT05979181 - Peripartum Cesarean Hysterectomy for Placenta Percreta
Recruiting NCT04609527 - Management of Placenta Accreta Spectrum Phase 2/Phase 3
Recruiting NCT06185894 - The Role of Using Tourniquet in Decreasing Bleeding in Placenta Accreta Spectrum Cases N/A
Completed NCT04573452 - Galectin-3 and Placenta Accreta
Not yet recruiting NCT03273569 - PDIUC Protocol for Placental Accreta N/A
Completed NCT03707132 - Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
Not yet recruiting NCT05104177 - Effectivness of Conservative Techniques in Management of PAS
Completed NCT02806024 - Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study Phase 4
Active, not recruiting NCT02784886 - Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta N/A
Recruiting NCT05070689 - Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS) N/A
Completed NCT05813743 - Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography N/A
Withdrawn NCT04003428 - Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA) N/A
Completed NCT04161521 - Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital N/A
Recruiting NCT05139498 - Conservative Management for PAS Pilot N/A
Not yet recruiting NCT03530475 - Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler N/A
Recruiting NCT05922397 - Placenta Accreta Spectrum Topographic Classification